tiprankstipranks
Clarity Pharmaceuticals Ltd. (AU:CU6)
:CU6
Australian Market
Holding AU:CU6?
Track your performance easily

Clarity Pharmaceuticals Ltd. (CU6) Income Statement

133 Followers

Clarity Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2022), Clarity Pharmaceuticals Ltd.'s total revenue was $―. In Q4, Clarity Pharmaceuticals Ltd.'s net income was $―. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
$ ―
Cost of Revenue
$ ―
Gross Profit
$ ―
Operating Expense
$ 30.29M
Operating Income
$ -30.29M
Net Non Operating Interest Income Expense
$ 95.09K
Other Income Expense
$ 6.46M
Pretax Income
$ -23.74M
Tax Provision
$ 17.63K
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -23.75M
Basic EPS
$ -0.10
Diluted EPS
$ -0.10
Basic Average Shares
$ 247.70M
Diluted Average Shares
$ 247.70M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ ―
Net Income From Continuing And Discontinued Operation
$ -23.75M
Normalized Income
$ -23.75M
Interest Expense
$ ―
EBIT
$ -30.29M
EBITDA
$ -30.24M
Currency in USD

Clarity Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis